samedan logo
 
 
 
spacer
home > pmps > summer 2003 > temperature-controlled distribution in the health care industry - a field of growing importance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Temperature-Controlled Distribution in the Health Care Industry - A Field of Growing Importance

According to John Taylor, a representative of the Quality Systems Division of the Medicines and Healthcare products Regulatory Agency (MHRA), around one quarter of all significant failures to comply with GDP are due to inadequate control and/or monitoring of the storage and transportation temperatures. While temperature-controlled distribution has always been important to the health care industry, the current biotechnological revolution has further increased the need for protection of thermally unstable products. At the same time, the health care supply chain is becoming more complex, with smaller and more frequent shipments, further increasing the demand on solutions.
Temperature-Sensitive Products are Growing in Importance

Although some observers believe that the rate of growth for the global health care industry will slow down considerably over the next few years, at the same time they agree that some segments will sustain or increase growth rates. One such segment, which is growing faster than the industry in general, is the biotechnology segment. Of the more than 130 biotechnology drugs and vaccines approved by the US Food and Drug Administration (FDA), 70 per cent were approved in the last six years according to the Biotechnology Industry Organisation, 2002. At the same time there are more than 350 biotech drug products and vaccines currently in clinical trials targeting more than 200 diseases according to the Biotechnology Industry Organisation, 2002. Many of these biotechnology drugs are temperature-sensitive. It is estimated that the temperature-sensitive segment is growing at a rate of about 15 per cent per year.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Robert Kayum, Manager of the Qualifications Team at Envirotainer

Robert Kayum is Manager of the Qualifications Team at Envirotainer. He previously workedfor Laminar Medica, manufacturers of insulated shipping systems for the pharmaceutical and biotechnology industry, where he obtained widespread experience in manufacturing.

At Laminar Medica, Robert assisted in building up the technical department, gaining a reputation for research, design, testing and consultancy of validated shipping systems for various pharmaceutical and biotechnological companies worldwide. He studied Applied Sciences at foundation level in Richmond upon Thames and won a place at Kings College to read Pharmacology.

spacer
Robert Kayum
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kirsten de Bruijn joins Qatar Airways Cargo

An Air Cargo veteran with 13 years of experience in management in the air cargo industry, she shares Qatar Airways belief that the pace of change brought about by recent global events demands value centred leadership around revenue and margin management.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement